A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793)

S Bellone, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
D M. Roque, Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, USA.
E R. Siegel, Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, USA.
N Buza, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
P Hui, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
E Bonazzoli, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
A Guglielmi, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
L Zammataro, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
N Nagarkatti, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
S Zaidi, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, USA.
J Lee, Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea.
D-A Silasi, Division of Gynecologic Oncology, Mercy Clinic, St. Louis, USA.
G S. Huang, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
V Andikyan, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
S Damast, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
M Clark, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
M Azodi, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.Follow
P E. Schwartz, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
J Tymon-Rosario, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
J Harold, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
D Mauricio, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
B Zeybek, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
G Menderes, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
G Altwerger, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
E Ratner, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
L B. Alexandrov, Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, USA.
A Iwasaki, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
Y Kong, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
E Song, Smilow Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
W Dong, Laboratory of Human Genetics and Genomics, The Rockefeller University, New York, USA.
J Elvin, Cancer Genomics Research, Foundation Medicine, Cambridge, USA.
J Choi, Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea.

Document Type

Article

Publication Title

Annals of oncology : official journal of the European Society for Medical Oncology

First Page

1045

Last Page

1046

DOI

10.1016/j.annonc.2021.04.013

Publication Date

8-1-2021

Identifier

33932502 (pubmed); NIHMS1830326 (mid); PMC9465821 (pmc); 10.1016/j.annonc.2021.04.013 (doi); S0923-7534(21)01170-4 (pii)

This document is currently not available here.

Share

COinS